Elekta, Karkinos Healthcare expand access to modern cancer care treatment across India
The deal will include several Elekta Versa HD linacs, which are designed to treat a spectrum of tumours
Elekta announced that Karkinos Healthcare will acquire more than ten linear accelerator (linac) systems to be strategically deployed across the country. The companies share the ambition to improve patient access to advanced precision cancer therapy.
The deal will include several Elekta Versa HD linacs, which are designed to treat a spectrum of tumours throughout the body supporting both conventional and highly sophisticated techniques, as well as many Elekta Harmony Pro systems, the company’s most productive linac yet, designed to provide the best in-room experience for both patients and healthcare professionals.
Manikandan Bala, MD for India, Elekta said, “The continuous rise of India’s cancer burden means that access to advanced cancer care technology remains a concerning public health challenge. Elekta’s collaboration with Karkinos Healthcare is a step towards strategically identifying these gaps and addressing such challenges. Through our synergies, we look forward to transforming the current cancer care landscape by increasing patient access to state-of-the-art precision radiotherapy solutions throughout India.”
R Venkataramanan, Founder and CEO, Karkinos Healthcare, added, “Cancer services in India have always seen a geographic skew towards big cities and southern India. We hope to play a small catalytic part in bringing greater equity in radiotherapy through our collaboration with Elekta, combining our strengths in technology and clinical expertise. With barely ten per cent of the desired radiotherapy capacity as per the recommendations of the World Health Organization in India, radiotherapy access has been a key area of focus for Karkinos.”
